Login / Signup
Fulminant hepatitis as an immune-related adverse event after nivolumab treatment.
Osamu Inamori
Aya Miyagawa-Hayashino
Akihisa Ueno
Fumiya Hongo
Yuta Sonobe
Tomohito Hojo
Eiichi Konishi
Published in:
Pathology international (2019)
Keyphrases
</>
hepatitis b virus
smoking cessation